Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Berberine

Berberine Hydrochloride · also known as Berberine, Dihydroberberine

Human clinical studies show that berberine can lower blood glucose and blood lipids, and this outcome evidence is fairly reliable. Its proposed molecular mechanisms, such as AMPK activation, come mostly from animal and cell experiments. Whether the same activation occurs in target tissues after usual oral doses has not been measured directly.

Typical dose: Standard berberine hydrochloride: 500 mg 2–3 times daily, before or with meals. Dihydroberberine: 100–200 mg 1–2 times daily.
Absorption and forms: Berberine is poorly absorbed from the gut, so only a small amount reaches the bloodstream, and its effects are mostly local to the intestine and gut microbiota. Dihydroberberine is a different derivative, not a synonym for berberine. Its advantages in absorption and tolerability cannot be assumed to apply to all formulations.

Clinical uses and human evidence

Blood sugar and insulin resistance

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Zhao 2023 · J Nutr · Meta-analysis · n=1761 — Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

High LDL cholesterol

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Blais 2023 · Drugs · Meta-analysis · n=1788 — Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
  2. Lei 2026 · JAMA Netw Open · RCT · n=337 — Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial

High triglycerides

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Blais 2023 · Drugs · Meta-analysis · n=1788 — Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Irritable bowel syndrome

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Chen 2015 · Phytother Res · RCT · n=132 — A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome

All-cause mortality risk

BeneficialGrade C · Preliminary evidence
Studies (1)
  1. Zeng 2003 · Am J Cardiol · RCT · n=156 — Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

Body weight and body fat

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Elahi Vahed 2026 · Int J Obes (Lond) · Meta-analysis — The effect of berberine on obesity indices: a systematic review and meta-analysis
  2. Lei 2026 · JAMA Netw Open · RCT · n=337 — Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial

Fatty liver and liver enzymes

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Nie 2024 · J Transl Med · Meta-analysis · n=811 — The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
  2. Lei 2026 · JAMA Netw Open · RCT · n=337 — Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD: A Randomized Clinical Trial

Polycystic ovary syndrome

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Wu 2016 · Fertil Steril · RCT · n=644 — Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome

High blood pressure

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Zamani 2022 · Front Nutr · Meta-analysis — The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
  2. Liu 2025 · Front Pharmacol · Meta-analysis — Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials

Mechanisms of action

AMPK sensing of cellular energy deficit and metabolic reprogramming

★★★☆☆Mechanism evidence: grade CSecondary target

Berberine can mildly inhibit the mitochondrial respiratory chain, which raises the intracellular AMP/ATP ratio and in turn activates AMPK. AMPK activation has been observed in rat skeletal muscle studies. However, whether the same happens in target tissues after usual oral dosing in humans has not been measured directly, and the drop in blood glucose does not by itself prove this mechanism.

References (2)
  1. 2010 · Rat skeletal muscle study: berberine increased AMPK Thr172 phosphorylation
  2. Combined assessment · Human evidence: no reliable human study with usual oral dosing has directly confirmed AMPK activation in the relevant tissues

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★★☆☆Mechanism evidence: grade CSecondary target

In mouse intestinal injury models and some cell models, berberine can improve the epithelial barrier, but a better barrier does not always come with higher total levels of tight junction proteins. Effects in humans and dependence on MLCK have yet to be verified, and there is no direct confirmation from intestinal biopsies.

References (2)
  1. 2025 · Mouse and human intestinal organoid study: tight junction proteins were protected in a mouse intestinal injury model
  2. 2013 · Caco-2 cell study: barrier function improved without a corresponding rise in total levels of all tight junction proteins

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade CSecondary target

In animal and cell inflammation models, berberine can inhibit TLR4 and NF-κB signaling and reduce the release of pro-inflammatory factors. Pathway inhibition after oral intake in humans has not been directly confirmed, and human cell experiments with berberine added in vitro are not equivalent to oral trials.

References (2)
  1. Liu et al. 2018 · Mouse colitis study: decreased p65 phosphorylation in macrophages
  2. Dang et al. 2023 · In vitro human cell study: high-micromolar berberine altered NF-κB-related signaling under inflammatory stimulation; participants did not take berberine orally in this experiment

Safety and drug interactions

Contraindicated in pregnancy and breastfeeding. Berberine can displace albumin-bound bilirubin, which carries a risk of neonatal kernicterus. Berberine can inhibit CYP3A4, CYP2D6, CYP2C9 and P-glycoprotein, and may raise blood levels of drugs such as cyclosporine, tacrolimus, some statins and digoxin. The size of the interaction varies by drug, and anyone taking prescription drugs must consult a doctor first. Combining it with glucose-lowering drugs such as metformin, insulin or sulfonylureas adds to the risk of low blood sugar. Long-term high doses may slightly alter the balance of gut microbiota, and there is currently not enough human evidence to support cyclic use.

Low blood sugar risk

Human trials confirmed it can lower blood sugar. Each of these may lower blood sugar. Taken together, especially on an empty stomach or alongside antidiabetic drugs, they may cause low blood sugar symptoms such as palpitations, shaking and cold sweats.

Inhibition of drug metabolism (CYP3A4 and others)

Inhibits CYP3A4, CYP2D6, CYP2C9 and P-glycoprotein. Each of these can inhibit the liver enzymes that metabolize drugs (mainly CYP3A4) or drug transporter proteins, raising blood levels of some prescription drugs.

With Sedative-hypnotics Needs attention

Diazepam, alprazolam, zolpidem, eszopiclone, sedating antihistamines

Berberine inhibits the metabolism of some sleep medications. In a small study, midazolam blood levels rose by about 40% after continuous berberine use, which may strengthen sedation. Its effect on other sleep medications is unclear.

With Digoxin Needs attention

Digoxin

Berberine can inhibit P-glycoprotein and may raise blood levels of digoxin. The evidence so far comes mainly from animal studies. If the two are taken together, monitoring digoxin levels is recommended.

Related lab tests

Fasting glucose and hemoglobin A1c Recheck while taking

Berberine lowers blood sugar. People with diabetes who use it should recheck HbA1c after about 3 months. People also taking glucose-lowering drugs should check blood sugar sooner and more often, and watch for low blood sugar.

Open in the interactive app ›